FCVAX | VISVX | FCVAX / VISVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 27 years | - |
Gain YTD | 7.249 | 14.945 | 49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.26B | 63B | 8% |
Annual Yield % from dividends | 0.42 | 1.90 | 22% |
Returns for 1 year | 8.50 | 16.18 | 53% |
Returns for 3 years | 2.26 | 20.58 | 11% |
Returns for 5 years | 38.43 | 52.67 | 73% |
Returns for 10 years | 14.55 | 105.07 | 14% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RMYYX | 9.83 | -0.02 | -0.20% |
Russell Inv Multi-Strategy Income Y | |||
VESIX | 35.16 | -0.14 | -0.40% |
Vanguard European Stock Instl | |||
ADOAX | 21.47 | -0.09 | -0.42% |
Axs Dynamic Opportunity A | |||
BMSSX | 14.50 | -0.16 | -1.09% |
MFS Blended Research Mid Cap Eq R2 | |||
NMPAX | 15.03 | -0.17 | -1.12% |
Columbia Mid Cap Index Inst |